What's hot
View all perspectives
What's Hot
RheumNow Rheumatology Roundup: Drs. Kavanaugh and Cush
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.
Watch video →
TNF Inhibitor Panel Discussion: ACR21 Annual Meeting
RheumNow TNFi faculty convened to discuss several TNFi-related abstracts presented at ACR 21. Panelists: Drs. Aurelie Najm, Janet Pope, David Liew, Eric Dein and Swetha Alexander.
Watch video →
Spondyloarthritis Panel Discussion: ACR21 Meeting
Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood. Abstracts discussed include #0562, #1919, #0907, #0364 and #0919
Watch video →
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.
Watch video →
Diagnosing (Bad) VEXAS: The Experts Speak Drs. Beck and Ferrada
Dr. Cush discusses Dr. Marcela Ferrada and Dr. David Beck to discuss VEXAS syndrome and abstract 1426, which was presented at the ACR21 annual meeting.
Watch video →
Pediatric Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses abstracts #1424 presented at the ACR21 annual meeting.
Watch video →
Urine Proteome Advances: What Do They Mean? Dr. Michelle Petri
Dr. Petri reviews abstracts #1422 and #1936, presented at the ACR21 annual meeting.
Watch video →
ACR21 Day 3 Recap: Polypharmacy, New Lupus Drugs, VEXAS, Safety Data
Blurb: Drs. Jack Cush and the RheumNow Faculty Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 (Monday) at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more.
Watch video →
Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles
Dr. Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting.
Watch video →
Predictors of TNF Response with Drs. Pope, Dein and Liew
Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448.
Watch video →
Caring for the Older Patient with Rheumatic Disease: Drs. Makris, Yung and Dao
Drs. Kathryn Dao, Una Makris and Raymond Yung discuss the field of geriatric rheumatology and caring for the older patient with rheumatic disease.
Watch video →
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares
Drs. Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna and Rachel Tate review autoinflammatory data presented at the ACR21 annual meeting, including abstracts #1100, #1062, #1426, #0252, #0195, and #1083.
Watch video →
FDA Session Review: Dr. Arthur Kavanaugh
Dr. Kavanaugh discussed the FDA session presented at the ACR21 annual meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.
Watch video →
The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer
Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the ACR21 annual meeting.
Watch video →
Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush
Dr. Cush reviews poster #1100 presented at the ACR21 annual meeting.
Watch video →
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri
Dr. Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the ACR21 annual meeting.
Watch video →
ACR21 Day 2 Recap: CV Risk, Tapering in SpA, Microbiome in PsA, Vit D
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 (Sunday) at the ACR21 Virtual meeting.
Watch video →
Robert B Chao, MD doctorRBC
4 years ago
Bimekizumab (IL-17A and IL-17Fi) 3 year safety and efficacy in PsA Phase IIb trial
⭐️no new safety signals
⭐️candida infections were all mild/moderate
⭐️efficacy consistent and maintained
Abs#491
#ACR21
@RheumNow
https://t.co/BK6xPMqAEM https://t.co/meoPd7k0Xp
Pedro Castillo _Castillo_Pedro
4 years ago
Dr. Atul Deodhar with an excellent presentation on treatment in axSpA and axPsA. Note ustekinumab and risankizumab did not show improvement in axSpA. However, these studies did not include axPsA.
@ACR21 6S403 @RheumNow https://t.co/F73lvpF2at
Pedro Castillo _Castillo_Pedro
4 years ago
More from Dr. Atul Deodhar on treatment of axSpA and axPsA. Guselkumab studies DISCOVER 1 & 2 looked at PsA with sacroiliitis and demonstrated improved measures of axial activity, but we need more studies and to include MR imaging.
#ACR21 6S403 session @RheumNow https://t.co/8jM5Fj8MuD
Olga Petryna DrPetryna
4 years ago
Abst 0370 #ACR21 @rheum survey of PCPs reveals lack of awareness about inflammatory back pain: 58%never/rarely assess for IBP; 40% not comfortable with making the dx of IBP. 83%never/rarely ordered HLAB27, 65% never/ rarely ordered CRP, 72% rarely/never ordered X-ray SI joint
Bella Mehta bella_mehta
4 years ago
New therapies this year in rheumatology #ACR21 year in review Avacopan in AAV and Voclosporin in Lupus nephritis @RheumNow @karen_kc123 https://t.co/8Z28STMJ6X
Bella Mehta bella_mehta
4 years ago
Using machine learning to predict knee cartilage worsening over 2 years sing gait and physical activity using the MOST study #abst0210 #ACR21 @RheumNow https://t.co/0MAjLhpL7t
Aurelie Najm AurelieRheumo
4 years ago
Overlap between RA and SLE: is the famous rhupus more frequent than it seems? In the Boston OM1 SLE Registry w/ 44,186 SLE: 4.7% also reported as having RA. This is higher than the usual reported prevalence. #ACR21 #Abst0354 @RheumNow https://t.co/FYfvSdCkkF https://t.co/ISuae2hCI3
Akhil Sood MD AkhilSoodMD
4 years ago
Abst 0281 England & colleagues used unsupervised ML to determine whether peripheral biomarkers can accurately identify RA-ILD in large RA cohort
- Identified 8 unique groups based on biomarkers
- RF, anti-CCP, and -MAA biomarkers most closely associated w/ ILD https://t.co/831tP4JSh0
Dr. John Cush RheumNow
4 years ago
Rheumatologists and Health Professionals: Join us tonight for RheumNow's #ACR21 Daily Recap at 7pm Eastern time . Register via the Zoom link below.
https://t.co/IQSL0mpEjR
Or visit our YouTube channel-RheumNow.
https://t.co/Nm74eS5T5H https://t.co/syaHSDJWOv
Pedro Castillo _Castillo_Pedro
4 years ago
PsA patients should be screened for spinal involvement, which may not be picked up on initially if we aren't looking for it. Presented by Dr. @annamolto
#ACR21 6S403 @RheumNow https://t.co/frB2zbHtXG
Janet Pope Janetbirdope
4 years ago
Early CV changes in #Rheumatoidarthritis abst#0271 showed more subclinical atherosclerosis vs controls in ERA, Abs ⬆️MACE &CV death in RA pts, abst#0269 ex RF, ACPA, MAA. Lipids ⬆️differently in RA given #tocilizumab vs TNFi BUT unrelated to CV events abst#0269 #ACR21 @RheumNow
Podcasts
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie00:20:18 -
Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao
00:20:26 -
The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell
00:35:26
Poster Hall